Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tejaswini Kulkarni

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Pulmonology Reports|December 14, 2020
Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treatTejaswini Kulkarni, Steven R Duncan
Cleveland Clinic Journal of Medicine|May 12, 2016
Extracorporeal membrane oxygenation in adults: A practical guide for internistsTejaswini Kulkarni, Nirmal S Sharma, Enrique Diaz-Guzman
BMJ Open|April 7, 2026
Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational studyJoseph Yang, Katy Sadowski, Akshay Kharat, et al.
Multidisciplinary Respiratory Medicine|May 17, 2023
Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung diseaseKevin G Dsouza, Amanda S Alexander, Jubal R Watts, et al.
American Journal of Respiratory Cell and Molecular Biology|January 8, 2016
Matrix Remodeling in Pulmonary Fibrosis and EmphysemaTejaswini Kulkarni, Philip O'Reilly, Veena B Antony, et al.
Thorax|April 3, 2026
Challenging the status quo for therapeutic clinical trials in fibrotic interstitial lung diseasesTejaswini Kulkarni, Manuela Funke-Chambour, Steve Jones, et al.
BMC Microbiology|October 12, 2016
DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in JapanTejaswini Kulkarni, Chihiro Aikawa, Takashi Nozawa, et al.
Pulmonary Therapy|July 29, 2024
The Impact of Autoantibodies on Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analyses of the Phase III ASCEND TrialTejaswini Kulkarni, Chad A Newton, Sachin Gupta, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 29, 2016
Alveolar epithelial disintegrity in pulmonary fibrosisTejaswini Kulkarni, Joao de Andrade, Yong Zhou, et al.
BMC Pulmonary Medicine|May 9, 2025
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative studyCamilla S Graham, Brianna Bisson, Jessica Shore, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Pulmonology Reports|December 14, 2020
Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treatTejaswini Kulkarni, Steven R Duncan
Cleveland Clinic Journal of Medicine|May 12, 2016
Extracorporeal membrane oxygenation in adults: A practical guide for internistsTejaswini Kulkarni, Nirmal S Sharma, Enrique Diaz-Guzman
BMJ Open|April 7, 2026
Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational studyJoseph Yang, Katy Sadowski, Akshay Kharat, et al.
Multidisciplinary Respiratory Medicine|May 17, 2023
Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung diseaseKevin G Dsouza, Amanda S Alexander, Jubal R Watts, et al.
American Journal of Respiratory Cell and Molecular Biology|January 8, 2016
Matrix Remodeling in Pulmonary Fibrosis and EmphysemaTejaswini Kulkarni, Philip O'Reilly, Veena B Antony, et al.
Thorax|April 3, 2026
Challenging the status quo for therapeutic clinical trials in fibrotic interstitial lung diseasesTejaswini Kulkarni, Manuela Funke-Chambour, Steve Jones, et al.
BMC Microbiology|October 12, 2016
DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in JapanTejaswini Kulkarni, Chihiro Aikawa, Takashi Nozawa, et al.
Pulmonary Therapy|July 29, 2024
The Impact of Autoantibodies on Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analyses of the Phase III ASCEND TrialTejaswini Kulkarni, Chad A Newton, Sachin Gupta, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 29, 2016
Alveolar epithelial disintegrity in pulmonary fibrosisTejaswini Kulkarni, Joao de Andrade, Yong Zhou, et al.
BMC Pulmonary Medicine|May 9, 2025
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative studyCamilla S Graham, Brianna Bisson, Jessica Shore, et al.
Pageof 5